Mechlorethamine: Uses, Side Effects & Dosage Info

Introduction

Mechlorethamine, also known as chlormethine, mustine, or HN2, is a nitrogen mustard alkylating agent used in chemotherapy to treat various types of cancer, particularly Hodgkin’s disease and lymphomas. It is administered under close supervision by a doctor either through injection or as a topical gel for cutaneous T-cell lymphomas and mycosis fungoides.

Medical Uses

Mechlorethamine is primarily indicated for the treatment of:

• Hodgkin’s disease
• Lymphosarcoma
• Chronic myelocytic leukemia
• Chronic lymphocytic leukemia

It may also be used topically to treat cutaneous T-cell lymphomas and mycosis fungoides. Mechlorethamine is often used in combination with other chemotherapy drugs such as vinblastine, procarbazine, and prednisone (the MOPP regimen).

Dosage and Administration

Mechlorethamine is a potent drug that must be administered under close physician supervision. The dosage varies depending on the specific condition being treated and individual patient factors. It is typically given through slow intravenous injection, although a topical gel formulation is available for certain skin cancers. Detailed dosing instructions are provided in the Mustargen package insert.

Side Effects and Precautions

Mechlorethamine can cause various side effects, including:

• Bone marrow suppression (neutropenia, anemia, thrombocytopenia)
• Nausea and vomiting
• Skin rash or hyperpigmentation
• Mouth sores
• Infertility

Serious adverse reactions may include secondary cancers, tumor lysis syndrome, and severe allergic reactions. Special precautions are necessary when handling this vesicant and necrotizing irritant.

Drug Interactions

Mechlorethamine may interact with various other medications, including:

• Other alkylating agents
• Immunosuppressants
• Live vaccines
• Drugs that affect bone marrow function

Patients should inform their doctor about all medications, supplements, and herbal products they are taking to avoid potentially harmful drug interactions . Food interactions are not well-established.

Mechanism of Action

As an alkylating agent, mechlorethamine works by forming covalent bonds with the DNA of cells, leading to DNA damage and cell death. This effect is most pronounced in rapidly dividing cells, such as cancer cells. The drug’s vesicant and necrotizing properties can also directly damage tissues.

History and Development

Mechlorethamine was one of the first anticancer drugs developed, derived from the nitrogen mustard war gas. It played a pivotal role in the birth of cancer chemotherapy in the 1940s. Initially known as Mustargen, it has been widely used to treat cancer, especially hematologic malignancies, for decades.

Current Research and Future Directions

While mechlorethamine remains an important tool in cancer treatment, research continues to develop newer targeted therapies and improve the efficacy and safety of existing alkylating agents. Combination regimens, dosing schedules, and drug delivery systems are active areas of study. Patient education, toxicity management, and supportive care are also key aspects of ongoing clinical research.